消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2021 CAG临床实践指南：炎症性肠病患者免疫接种—第2部分：灭活疫苗

2021-08-01 加拿大胃肠病学协会 Gastroenterology

炎症性肠病胃肠疾病

2021年8月，加拿大胃肠病学协会(CAG)发布了炎症性肠病患者免疫接种指南第2部分—灭火疫苗的应用。本文主要针对炎症性肠病患者接种灭活活疫苗的相关内容提供指导建议。

中文标题：

2021 CAG临床实践指南：炎症性肠病患者免疫接种—第2部分：灭活疫苗

英文标题：

Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines

发布机构：

加拿大胃肠病学协会

发布日期：

2021-08-01

简要介绍：

2021年8月，加拿大胃肠病学协会(CAG)发布了炎症性肠病患者免疫接种指南第2部分—灭火疫苗的应用。本文主要针对炎症性肠病患者接种灭活活疫苗的相关内容提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 CAG临床实践指南：炎症性肠病患者免疫接种—第2部分：灭活疫苗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d415b1c0022691f1, title=2021 CAG临床实践指南：炎症性肠病患者免疫接种—第2部分：灭活疫苗, enTitle=Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated Vaccines, guiderFrom=Gastroenterology, authorId=0, author=, summary=2021年8月，加拿大胃肠病学协会(CAG)发布了炎症性肠病患者免疫接种指南第2部分&mdash;灭火疫苗的应用。本文主要针对炎症性肠病患者接种灭活活疫苗的相关内容提供指导建议。, cover=https://img.medsci.cn/20211122/1637562217872_1608702.jpg, journalId=0, articlesId=null, associationId=716, associationName=加拿大胃肠病学协会, associationIntro=加拿大胃肠病学协会(CAG)成立于1962年，该协会现有成员1100多个，包括胃肠科医生，外科医生，儿科医生，基础研究者和护士等。协会的目的是进行消化道的健康和疾病研究，通过指导患者护理、教学、持续专业发展促进胃肠道科学发展，提倡并维护最高的道德标准。CAG注重教育职能，协会网站设有Physician Education栏目，为会员提供继续医学教育、培训项目等信息。 协会每年2月末都举办加拿大消化疾病周会议(CDDW)，分为临床和基础两个会场，参会人员包括胃肠病学、肝病学、内镜和胃肠外科等专业的医生和研究人员。CAG还注重患者教育，从首页可链接到加拿大消化道健康基金会(CDHF)为患者介绍消化系统疾病的相关知识。, copyright=0, guiderPublishedTime=Sun Aug 01 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年8月，加拿大胃肠病学协会(CAG)发布了炎症性肠病患者免疫接种指南第2部分&mdash;灭火疫苗的应用。本文主要针对炎症性肠病患者接种灭活活疫苗的相关内容提供指导建议。</span></p>, tagList=[TagDto(tagId=1125, tagName=炎症性肠病), TagDto(tagId=9798, tagName=胃肠疾病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1125, guiderKeyword=炎症性肠病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=6, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2503, appHits=46, showAppHits=0, pcHits=328, showPcHits=2457, likes=0, shares=4, comments=4, approvalStatus=1, publishedTime=Mon Nov 22 14:27:34 CST 2021, publishedTimeString=2021-08-01, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Mon Nov 22 14:27:27 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Thu Jan 04 15:17:44 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 CAG临床实践指南：炎症性肠病患者免疫接种—第2部分：灭活疫苗.pdf)])
2021 CAG临床实践指南：炎症性肠病患者免疫接种—第2部分：灭活疫苗.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1193786, encodeId=36ee1193e8680, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b6504972, createdName=ms5000001210642601, createdTime=Tue Feb 15 22:06:53 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082355, encodeId=5f561082355f5, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:40:27 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073391, encodeId=e58610e339143, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Nov 24 07:05:17 CST 2021, time=2021-11-24, status=1, ipAttribution=)]
    2022-02-15 ms5000001210642601

    好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1193786, encodeId=36ee1193e8680, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b6504972, createdName=ms5000001210642601, createdTime=Tue Feb 15 22:06:53 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082355, encodeId=5f561082355f5, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:40:27 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073391, encodeId=e58610e339143, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Nov 24 07:05:17 CST 2021, time=2021-11-24, status=1, ipAttribution=)]
    2021-12-21 龙珠

    学习好资料！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1193786, encodeId=36ee1193e8680, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=639b6504972, createdName=ms5000001210642601, createdTime=Tue Feb 15 22:06:53 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082355, encodeId=5f561082355f5, content=学习好资料！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Tue Dec 21 08:40:27 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1073391, encodeId=e58610e339143, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Nov 24 07:05:17 CST 2021, time=2021-11-24, status=1, ipAttribution=)]
    2021-11-24 微探

    学习学习

    0

相关指南

2021 CAG临床实践指南：炎症性肠病患者免疫接种—第1部分：活疫苗

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2021-02-19

2021 WSES/AAST指南：炎症性肠病的急诊管理

世界急诊外科学会(WSES,World Society of Emergency Surgery) · 2021-05-11

2021 国际共识：炎症性肠病患者静脉和动脉血栓性事件的预防

国外消化科相关专家小组（统称） · 2021-08-27

关于炎症性肠病静脉血栓栓塞风险、预防和治疗的共识声明：加拿大胃肠病学协会

美国胸科医师学会(ACCP,American College of Chest Physicians) · 2021-09-01

炎症性肠病患者静脉和动脉血栓事件预防国际共识

国际炎症性肠病研究组织(IOIBD,International Organization For the Study of Inflammatory Bowel Disease) · 2021-09-01

2021 WSES_AAST指南：炎症性肠病的急诊管理

世界急诊外科学会(WSES,World Society of Emergency Surgery) · 2021-05-11

拓展阅读

2014年加拿大炎症性肠病（IBD）与静脉血栓防治共识意见：加拿大胃肠病学会

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2014-03-01

2014 ESPGHAN儿童和青少年炎症性肠病诊断的波尔图标准（修订版）

欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN,European Society for Paediatric Gastroenterology, Hepatology, and Nutrition) · 2014-06-10

2014 CAG立场声明：应用巯嘌呤类药物治疗炎症性肠病

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2014-07-04

2015 ASGE指南：内镜检查在炎症性肠病中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2015-03-20

2016 建立我国炎症性肠病诊治中心质量控制指标的共识

中华医学会消化病学分会炎症性肠病学组 · 2016-07-30

2017 IG-IBD临床实践指南：应用糖皮质激素和免疫抑制药物治疗炎症性肠病

意大利炎症性肠病研究组(IG-IBD,Italian Group for the Study of Inflammatory Bowel Disease) · 2017-01-25